Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: Mama Bear who wrote (1913)	4/16/1999 11:25:00 AM
From: Don Dorsey	Read Replies (1) \| Respond to of 2135

What most professionals disagree with is the ability to consistently time the market or a particular stock successfully. I'm not implying you can't do it, just that if you can you are one of the special few. That's all I commented on because I'm not interested in engaging in a debate. I'm just trying to gather information. For me ENMD is a risk/reward play. I can lose at most 100% of a small stake, but I stand to make many thousands of percent if the trails succeed. Risk is something I don't think the shorts appreciate. Out of a 7.7 mil float, there are 1.8 mil shares short. I wouldn't want to risk holding those shorts as trials begin, and risk the stock opening above 100 one morning if good news is leaked.